Angelita Rebamontan Domingo Sells 998 Shares of Pro-Dex (NASDAQ:PDEX) Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Angelita Rebamontan Domingo sold 998 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $47.24, for a total transaction of $47,145.52. Following the completion of the transaction, the director owned 18,779 shares of the company’s stock, valued at approximately $887,119.96. This trade represents a 5.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Pro-Dex Price Performance

Shares of NASDAQ:PDEX opened at $56.54 on Thursday. The firm has a market cap of $180.36 million, a PE ratio of 15.62 and a beta of 0.01. The firm’s fifty day moving average is $62.14 and its 200-day moving average is $51.06. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.14 and a current ratio of 3.67. Pro-Dex, Inc. has a 52 week low of $23.47 and a 52 week high of $68.99.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.58. The company had revenue of $19.95 million for the quarter, compared to analysts’ expectations of $17.90 million. Pro-Dex had a net margin of 16.08% and a return on equity of 22.78%. Sell-side analysts predict that Pro-Dex, Inc. will post 3.16 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of PDEX. Punch & Associates Investment Management Inc. grew its holdings in Pro-Dex by 23.4% in the fourth quarter. Punch & Associates Investment Management Inc. now owns 60,000 shares of the medical instruments supplier’s stock worth $2,309,000 after purchasing an additional 11,392 shares during the period. Morgan Dempsey Capital Management LLC raised its holdings in shares of Pro-Dex by 33.1% during the third quarter. Morgan Dempsey Capital Management LLC now owns 5,469 shares of the medical instruments supplier’s stock valued at $185,000 after purchasing an additional 1,360 shares during the period. Royal Bank of Canada boosted its position in shares of Pro-Dex by 603.4% during the 4th quarter. Royal Bank of Canada now owns 4,080 shares of the medical instruments supplier’s stock worth $157,000 after purchasing an additional 3,500 shares in the last quarter. First Trust Advisors LP bought a new position in Pro-Dex in the fourth quarter worth approximately $222,000. Finally, Wells Fargo & Company MN grew its stake in Pro-Dex by 65.4% in the fourth quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier’s stock valued at $89,000 after acquiring an additional 915 shares during the period. Institutional investors and hedge funds own 15.28% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on PDEX. Weiss Ratings raised Pro-Dex from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, July 1st. Wall Street Zen upgraded shares of Pro-Dex from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Ascendiant Capital Markets lifted their target price on shares of Pro-Dex from $56.00 to $70.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Finally, Zacks Research upgraded shares of Pro-Dex to a “hold” rating in a report on Tuesday, May 19th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $70.00.

Pro-Dex Company Profile

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.